Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
8.56M
-
Number of holders
-
148
-
Total 13F shares, excl. options
-
85.7M
-
Shares change
-
+59.6K
-
Total reported value, excl. options
-
$1.23B
-
Value change
-
-$3.13M
-
Put/Call ratio
-
0.3
-
Number of buys
-
80
-
Number of sells
-
-60
-
Price
-
$14.36
Significant Holders of Atara Biotherapeutics, Inc. - Common Stock (ATRA) as of Q1 2021
173 filings reported holding ATRA - Atara Biotherapeutics, Inc. - Common Stock as of Q1 2021.
Atara Biotherapeutics, Inc. - Common Stock (ATRA) has 148 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 85.7M shares
.
Largest 10 shareholders include BAUPOST GROUP LLC/MA (8.48M shares), BlackRock Inc. (6.95M shares), Redmile Group, LLC (6.89M shares), MAVERICK CAPITAL LTD (6.74M shares), JPMORGAN CHASE & CO (6.71M shares), VANGUARD GROUP INC (6.35M shares), STATE STREET CORP (4.41M shares), MORGAN STANLEY (3.18M shares), CREDIT SUISSE AG/ (2.51M shares), and GOLDMAN SACHS GROUP INC (2.12M shares).
This table shows the top 148 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.